• 872 - Ketamine and Esketamine

  • Mar 20 2025
  • Length: 17 mins
  • Podcast

872 - Ketamine and Esketamine

Listen for free

View show details

  • Summary

  • About this episode: Ketamine is in the news again. In this episode: a conversation about the differences between ketamine and esketamine—an FDA-approved medicine for treatment-resistant depression—why we’re hearing so much about ketamine right now, and the importance of administering esketamine in a clinical setting as part of a broader comprehensive mental health strategy. Guest: is a psychiatrist and director of the . is a psychiatrist and co-director of the . Host: Lindsay Smith Rogers, MA, is the producer of the , an editor for , and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: —Johns Hopkins Bloomberg School of Public Health —Hopkins Medicine —The Atlantic Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us or . Follow us: Here's our
    Show more Show less
Show more Show less

What listeners say about 872 - Ketamine and Esketamine

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available